BACKGROUND: Hematopoietic stem-cell transplant (HSCT) is associated with many risk factors for life-threatening complications. Post-transplant critical illness often requires admission to the pediatric intensive care unit (PICU). METHODS: A retrospective analysis was made on the risk factors associated with PICU admission and mortality of all HSCT patients at Helen DeVos Children's Hospital from October 1998 to November 2008. RESULTS: One hundred and twenty-four patients underwent HSCT, with 19 (15.3%) requiring 29 PICU admissions. Fifty patients received autologous, 38 matched sibling, and 36 matched un-related donor HSCT, with 10%, 13% and 25% of these patients requiring PICU admission, respectively (P=0.01). Among the HSCT patients, those who were admitted to the PICU were more likely to have renal involvement by either malignancy requiring nephrectomy or a post transplant complication increasing the likelihood of decreased renal function (21.1% vs. 4.8%, P=0.03). PICU admissions were also more likely to receive pre-transplant total body irradiation (52.6% vs. 27.6%, P=0.03). Among 29 patients with PICU admission, 3 died on day 1 after admission, and 5 within 30 days (a mortality rate of 17%). Thirty days after PICU admission, non-survivors had a higher incidence of respiratory failure and septic shock on admission compared with survivors (80% vs. 16.7%, P=0.01 and 80% vs. 4.2%, respectively, P=0.001). Two survivors with chronic renal failure underwent renal transplantation successfully. CONCLUSIONS: Total body irradiation and renal involvement are associated with higher risk for PICU admissions after HSCT in pediatric patients, while septic shock upon admission and post-admission respiratory failure are associated with mortality.
BACKGROUND: Hematopoietic stem-cell transplant (HSCT) is associated with many risk factors for life-threatening complications. Post-transplant critical illness often requires admission to the pediatric intensive care unit (PICU). METHODS: A retrospective analysis was made on the risk factors associated with PICU admission and mortality of all HSCT patients at Helen DeVos Children's Hospital from October 1998 to November 2008. RESULTS: One hundred and twenty-four patients underwent HSCT, with 19 (15.3%) requiring 29 PICU admissions. Fifty patients received autologous, 38 matched sibling, and 36 matched un-related donor HSCT, with 10%, 13% and 25% of these patients requiring PICU admission, respectively (P=0.01). Among the HSCT patients, those who were admitted to the PICU were more likely to have renal involvement by either malignancy requiring nephrectomy or a post transplant complication increasing the likelihood of decreased renal function (21.1% vs. 4.8%, P=0.03). PICU admissions were also more likely to receive pre-transplant total body irradiation (52.6% vs. 27.6%, P=0.03). Among 29 patients with PICU admission, 3 died on day 1 after admission, and 5 within 30 days (a mortality rate of 17%). Thirty days after PICU admission, non-survivors had a higher incidence of respiratory failure and septic shock on admission compared with survivors (80% vs. 16.7%, P=0.01 and 80% vs. 4.2%, respectively, P=0.001). Two survivors with chronic renal failure underwent renal transplantation successfully. CONCLUSIONS: Total body irradiation and renal involvement are associated with higher risk for PICU admissions after HSCT in pediatric patients, while septic shock upon admission and post-admission respiratory failure are associated with mortality.
Authors: André Tichelli; Alicia Rovó; Jakob Passweg; Carl Philipp Schwarze; Maria Teresa Van Lint; Mutlu Arat; Gérard Socié Journal: Expert Rev Hematol Date: 2009-10 Impact factor: 2.929
Authors: Josephus P J van Gestel; Casper W Bollen; Marc B Bierings; Jaap Jan Boelens; Nico M Wulffraat; Adrianus J van Vught Journal: Biol Blood Marrow Transplant Date: 2008-12 Impact factor: 5.742
Authors: Andrew S Moore; Peter J Shaw; Andrew R Hallahan; Tina L Carter; Tatjana Kilo; Ian Nivison-Smith; Tracey A O'Brien; Heather Tapp; Lochie Teague; Shaun R Wilson; Karin Tiedemann Journal: Med J Aust Date: 2009-02-02 Impact factor: 7.738
Authors: M R Bishop; B R Logan; S Gandham; B J Bolwell; J-Y Cahn; H M Lazarus; M R Litzow; D I Marks; P H Wiernik; P L McCarthy; J A Russell; C B Miller; J Sierra; G Milone; A Keating; F R Loberiza; S Giralt; M M Horowitz; D J Weisdorf Journal: Bone Marrow Transplant Date: 2007-12-17 Impact factor: 5.483
Authors: N Maximova; G Ferrara; M Minute; A Pizzol; V Kiren; M Montico; M Gregori; P Tamaro Journal: Int J Hematol Date: 2014-04-09 Impact factor: 2.490